Drug class · Pain & inflammation
Opioid agonists Drug Codes & NDCs
Drugs that activate opioid receptors. Most are DEA-scheduled; the schedule is shown on each NDC record.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 2 mg/mL | InjectionIntramuscular, Intravenous, Subcutaneous | Hikma Pharmaceuticals USA Inc. | 0641-6170 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride .5 mg/.5mL | InjectionIntramuscular, Intravenous, Subcutaneous | Hikma Pharmaceuticals USA Inc. | 0641-6206 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 2 mg/mL | Injection, SolutionIntramuscular, Intravenous, Subcutaneous | Hikma Pharmaceuticals USA Inc. | 0641-6254 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride .2 mg/mL | InjectionIntramuscular, Intravenous, Subcutaneous | Hikma Pharmaceuticals USA Inc. | 0641-6259 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 10 mg/mL | Injection, SolutionIntramuscular, Intravenous, Subcutaneous | Teva Parenteral Medicines, Inc. | 0703-0018 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 10 mg/mL | Injection, SolutionIntramuscular, Intravenous, Subcutaneous | Teva Parenteral Medicines, Inc. | 0703-0110 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 10 mg/mL | Injection, SolutionIntramuscular, Intravenous, Subcutaneous | Teva Parenteral Medicines, Inc. | 0703-0113 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 2 mg/1 | TabletOral | Aurolife Pharma, LLC | 13107-107 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 4 mg/1 | TabletOral | Aurolife Pharma, LLC | 13107-108 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 8 mg/1 | TabletOral | Aurolife Pharma, LLC | 13107-109 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 8 mg/1 | Tablet, Extended releaseOral | Trigen Laboratories, LLC | 13811-701 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 12 mg/1 | Tablet, Extended releaseOral | Trigen Laboratories, LLC | 13811-702 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 16 mg/1 | Tablet, Extended releaseOral | Trigen Laboratories, LLC | 13811-703 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 32 mg/1 | Tablet, Extended releaseOral | Trigen Laboratories, LLC | 13811-704 |
| hydromorphone hydrochloride | Hydromorphone hydrochloride 8 mg/1 | Tablet, Extended releaseOral | Camber Pharmaceuticals, Inc. | 31722-119 |
| hydromorphone hydrochloride | Hydromorphone hydrochloride 12 mg/1 | Tablet, Extended releaseOral | Camber Pharmaceuticals, Inc. | 31722-120 |
| hydromorphone hydrochloride | Hydromorphone hydrochloride 16 mg/1 | Tablet, Extended releaseOral | Camber Pharmaceuticals, Inc. | 31722-121 |
| hydromorphone hydrochloride | Hydromorphone hydrochloride 32 mg/1 | Tablet, Extended releaseOral | Camber Pharmaceuticals, Inc. | 31722-122 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 2 mg/1 | TabletOral | Rhodes Pharmaceuticals LLC | 42858-301 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 4 mg/1 | TabletOral | Rhodes Pharmaceuticals LLC | 42858-302 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 8 mg/1 | TabletOral | Rhodes Pharmaceuticals LLC | 42858-303 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 5 mg/5mL | SolutionOral | Rhodes Pharmaceuticals LLC | 42858-304 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 5 mg/5mL | SolutionOral | Ascent Pharmaceuticals Inc | 43602-001 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 2 mg/1 | TabletOral | Ascent Pharmaceuticals Inc | 43602-002 |
| Hydromorphone Hydrochloride | Hydromorphone hydrochloride 4 mg/1 | TabletOral | Ascent Pharmaceuticals Inc | 43602-003 |